Long-Term Experience With Sandimmun Neoral: Results in De Novo and Stable Renal Transplant Patients After 24-Month Treatment

By German Neoral Study Group   Korn A.   Farber L.   Maibucher A.   Buchholz B.   Offermann G.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2945-2947

Elsevier

Access to resources Recommend Favorite

Neoral vs Sandimmun: Interim Results of a Randomized Trial of Efficacy and Safety in Preventing Acute Rejection in New Renal Transplant Recipients

By U.K. Neoral Study Group   Lodge J.P.A.   Pollard S.G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 272-273

Elsevier

Access to resources Recommend Favorite

A one-year comparative study of neoral vs consupren in de novo renal transplant patients

By Stephan A.   Masri M.A.   Barbari A.   Aoun S.   Rizk S.   Kamel G.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3533-3534

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic study of twice vs thrice daily dosing of sandimmun neoral in pediatric renal transplant patients - A New Formulation of Ciclosporine

By Papachristou F.   Gakis D.   Sotiriou I.   Liatsis I.   Takoudas D.   Antoniadis A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1988-1990

Elsevier

Access to resources Recommend Favorite

Comparison of Neoral and Sandimmun Cyclosporines for De Novo Lung Transplantation in Cystic Fibrosis Patients

By Mikhail G.   Eadon H.   Leaver N.   Khaghani A.   Yacoub M.   Banner N.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1510-1511

Elsevier

Access to resources Recommend Favorite